top of page

12th Annual General Meeting of the BioLawEurope organisation in Prague, Czech Republic on 21 - 23 May 2026

BioLawEurope
Oct 20
1 min read

We ♥️ Life Sciences – BioLawEurope AGM 2026 in Prague

 

Insightful discussions, fresh perspectives and inspiring exchanges at this year’s BioLawEurope Annual General Meeting in beautiful Prague once again demonstrated the importance of cross-border dialogue💡

 

Our professional program focused on some key regulatory and market developments in the life sciences and healthcare sector across Europe (plus interesting insights from our US member Brian Hand), including:

 

  • the evolving role of pharmacies within primary care delivery models – presented by Igor Pieš

  • a comparative survey on university spin-outs, focusing on IP allocation mechanisms, legal frameworks and equity participation models practices across the BLE members' jurisdictions – presented by Jan Bjerrum Bach based on contributions from BioLawEurope members

  • clinical trial data and the evolving impact of the European Health Data Space (EHDS) and the EU Digital Omnibus initiative – presented by Agnieszka Wozniak

 

We likewise had an engaging exchange on the potential implications of the US “Most Favored Nation” pharmaceutical pricing policy for drug pricing and availability across Europe – and many further discussions.

 

A heartfelt thank you to our wonderful hosts Igor Pieš and Eliška Toušková for the warm welcome, outstanding organization and making us experience true Prague hospitality. 🇨🇿

 

And a sincere thank you to all BioLawEurope members and participants for the lively talks, valuable insights and continued collaboration across the BioLawEurope network. Looking forward to meet up again – latest next year in beautiful Stockholm! 🇸🇪 


Annual General Meeting 2026
Annual General Meeting 2026

 


Comments


BioLawEurope

c/o VISCHER AG
Schützengasse 1
8001 Zürich

bottom of page